Ankit Mahadevia's recent sale below the current price of US$...
Ankit Mahadevia's recent sale below the current price of US$1.45 is seen as discouraging, suggesting satisfaction with a lower valuation. The lack of insider purchases over the last year and low level of insider ownership compared to most companies raises caution for potential investors.
Don't Ignore The Insider Selling In Spero Therapeutics
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment